The physiotherapy equipment market size is expected to grow from USD 22.37 billion in 2025 to USD 23.89 billion in 2026 and is forecast to reach USD 33.26 billion by 2031 at 6.85% CAGR over 2026-2031. This report is Segmented by Equipment Type (Electrotherapy, Ultrasound, Laser, and More), Application (Musculoskeletal, Neurology, Cardiopulmonary, Sports Injuries, Pediatrics, Women's Health, Pain Management), End User (Hospitals, Rehab Centers, Home-Care, Ascs, Sports Medicine), and Geography (North America, Europe, APAC, MEA, South America). Forecasts in Value (USD).
Wearable and assistive devices are projected to grow at a 7.12% annual rate through 2031. The costs of inertial sensors have dropped below USD 5, allowing for 6-axis motion tracking in braces and straps that retail at consumer-friendly price points. These devices collect adherence data that feed payer dashboards, a capability traditional clinic-bound systems lack. Multi-exercise stations are losing ground in home settings, whereas hydrotherapy remains confined to hospitals where space and maintenance budgets are available.
Asia-Pacific is the fastest-growing region at a 7.62% CAGR, propelled by China’s Healthy China 2030 mandate requiring rehabilitation departments in all tertiary hospitals. India’s Ayushman Bharat extended coverage to 500 million citizens, encouraging private providers to expand rehabilitation capacity. Japan’s super-aging society funneled USD 2.1 billion into robotic mobility aids in 2024-2025, elevating physiotherapy equipment market penetration.
Europe contributes roughly one-quarter of global value. Stringent EU MDR rules have raised compliance costs, favoring well-resourced manufacturers. The Middle East and Africa remain nascent, though the United Arab Emirates and Saudi Arabia are investing under Vision 2030. South America, led by Brazil, is advancing steadily at 5-6%, but currency volatility tempers capital spending.
Global Physiotherapy Equipment Market Trends and Insights
Rising Geriatric Population & Chronic Disease Burden
According to the World Health Organization, the proportion of the geriatric population is expected to nearly double from 12% to 22% of the global population. Older demographics experience higher rates of osteoarthritis, stroke, and chronic pain, pushing demand for automated gait trainers, electrotherapy units, and balance systems. WHO’s Rehabilitation 2030 agenda highlights a 40% therapist shortfall in lower-income regions, prompting suppliers to build devices that lower clinician-to-patient ratios. As chronic disease prevalence rises, the physiotherapy equipment market is positioned for sustained volume growth.Rapid Adoption of Connected & Portable Physiotherapy Devices
Payers are encouraging home-based care to reduce inpatient costs, and portable electrotherapy units priced at USD 300-500 are reshaping purchasing patterns. Medicare removed prior authorization for physician-prescribed DME in 2024, helping Zynex Medical shift the majority of revenue to direct-to-consumer channels. Embedded inertial measurement sensors stream compliance data that insurers use to validate therapy adherence. New FDA cybersecurity guidance obliges suppliers to disclose software bills of materials, raising technical barriers but standardizing data protocols. Collectively, these dynamics are enlarging the connected-device share of the physiotherapy equipment market.Other drivers and restraints analyzed in the detailed report include:
- AI-Driven Tele-Rehabilitation Platforms Gaining Reimbursement
- Exoskeleton & Robotics Integration in Physiotherapy Suites
- Shortage of Skilled Physiotherapists Worldwide
- Unfavorable or Patchy Reimbursement in Developing Markets
Segment Analysis
Electrotherapy accounted for a 36.7% physiotherapy equipment market share in 2025, buoyed by decades of evidence for pain control and neuromuscular re-education. Ultrasound and laser modalities added close to 20% combined share as sports clinics adopted tissue-healing technologies. Despite entrenched demand, the physiotherapy equipment market size for electrotherapy is moderating, while the wearable sub-segment is accelerating.Wearable and assistive devices are projected to grow at a 7.12% annual rate through 2031. The costs of inertial sensors have dropped below USD 5, allowing for 6-axis motion tracking in braces and straps that retail at consumer-friendly price points. These devices collect adherence data that feed payer dashboards, a capability traditional clinic-bound systems lack. Multi-exercise stations are losing ground in home settings, whereas hydrotherapy remains confined to hospitals where space and maintenance budgets are available.
Complete Report Scope:
- By Equipment Type
- Electrotherapy
- Ultrasound Therapy
- Laser & Light Therapy
- Shockwave Therapy
- Magnetic & PEMF Therapy
- Heat & Cryotherapy Systems
- Hydrotherapy Systems
- Multi-exercise & Rehabilitation Stations
- Wearable & Assistive Rehabilitation Devices
- By Application
- Musculoskeletal
- Neurology
- Cardiovascular & Pulmonary
- Sports & Orthopedic Injuries
- Pediatrics
- Women’s Health & OB/GYN
- Pain Management & Chronic Care
- By End User
- Hospitals
- Rehabilitation Centers / Specialty Clinics
- Home-care Settings
- Ambulatory Surgical Centers
- Sports Medicine Centers
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America generated 39.4% of 2025 revenue, supported by Medicare coverage of tele-rehabilitation and a vast outpatient clinic network. The physiotherapy equipment market size in the United States benefits from new RTM codes that reward connected devices. Canada’s private clinics charge USD 60-90 per session, prompting investments in wearables to enhance service differentiation.Asia-Pacific is the fastest-growing region at a 7.62% CAGR, propelled by China’s Healthy China 2030 mandate requiring rehabilitation departments in all tertiary hospitals. India’s Ayushman Bharat extended coverage to 500 million citizens, encouraging private providers to expand rehabilitation capacity. Japan’s super-aging society funneled USD 2.1 billion into robotic mobility aids in 2024-2025, elevating physiotherapy equipment market penetration.
Europe contributes roughly one-quarter of global value. Stringent EU MDR rules have raised compliance costs, favoring well-resourced manufacturers. The Middle East and Africa remain nascent, though the United Arab Emirates and Saudi Arabia are investing under Vision 2030. South America, led by Brazil, is advancing steadily at 5-6%, but currency volatility tempers capital spending.
List of Companies Covered in this Report:
- AlterG
- BTL
- Chinesport
- Dynatronics
- EMS Physio
- Enovis Corporation (DJO Global Inc.)
- Guangzhou Longest Science & Technology Co., Ltd.
- HMS Medical system
- Hocoma
- ITO Co. Ltd.
- Lifeward, Inc.
- Lusio Rehabilitation
- Mectronic Medicale
- Meden-Inmed
- Patterson Medical (Performance Health)
- Restorative Therapies
- ReWalk Robotics
- SEERS Medical
- Zimmer MedizinSysteme (Enraf-Nonius BV)
- Zynex Medical
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts (Value)
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AlterG
- BTL Industries
- Chinesport
- Dynatronics
- EMS Physio
- Enovis Corporation (DJO Global Inc.)
- Guangzhou Longest Science & Technology Co., Ltd.
- HMS Medical Systems
- Hocoma
- ITO Co. Ltd.
- Lifeward, Inc.
- Lusio Rehabilitation
- Mectronic Medicale
- Meden-Inmed
- Patterson Medical (Performance Health)
- Restorative Therapies
- ReWalk Robotics
- SEERS Medical
- Zimmer MedizinSysteme (Enraf-Nonius BV)
- Zynex Medical Inc.
